Eric M Tam (Eric Tam)

Publication Activity (10 Years)

Years Active: 2019-2020
Publications (10 Years): 2

Top Topics

Metastatic Breast Cancer

Immune Response

Dendritic Cells

Top Venues

Science translational medicine

Molecular cancer therapeutics

Merrimack Pharmaceuticals Inc

University of British Columbia (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Merrimack Pharmaceuticals Inc

United States

Director :: Research

XOMA Limited

United States

Scientist :: Research

Catalyst Biosciences Inc

United States

Scientist :: Research

Genentech Inc

United States

Postdoctoral fellow :: Protein Engineering

Education History

University of British Columbia

Canada

PHD :: Biochemistry

University of British Columbia

Canada

BSC :: Biochemistry

Publications

Eric M Tam, Ross B Fulton, James F Sampson, Marco Muda, Adam Camblin, Jennifer Richards, Alexander Koshkaryev, Jian Tang, Vinodh Kurella, Yang Jiao, Lihui Xu, Kathy Zhang, Neeraj Kohli, Lia Luus, Elizabeth Hutto, Sandeep Kumar, James Lulo, Violette Paragas, Christina S F Wong, James J Suchy, Stephanie Grabow, Anne-Sophie Dugast, Hong Zhang, Fabien Depis, Sonia Feau, Aniela Jakubowski, Wenlian Qiao, Galina Craig, Maja Razlog, James Qiu, Yu Zhou, James D Marks, Michael Croft, Daryl C Drummond, Andreas Raue
Antibody-mediated targeting of TNFR2 activates CD8+ T cells in mice and promotes antitumor immunity. Science translational medicine 11 (512) (2020)
Walid S Kamoun, Anne-Sophie Dugast, James J Suchy, Stephanie Grabow, Ross B Fulton, James F Sampson, Lia Luus, Michael Santiago, Alexander Koshkaryev, Gang Sun, Vasileios Askoxylakis, Eric M Tam, Zhaohua Richard Huang, Daryl C Drummond, Andrew J Sawyer
Synergy between EphA2-ILs-DTXp, a Novel EphA2-Targeted Nanoliposomal Taxane, and PD-1 Inhibitors in Preclinical Tumor Models. Molecular cancer therapeutics 19 (1) (2019)